Pulmonary administration of a dry powder formulation of the antifibrotic drug tilorone reduces silica-induced lung fibrosis in mice

Vartiainen, V; Raula, J; Bimbo, LM; Viinamaki, J; Backman, JT; Ugur, N; Kauppinen, E; Sutinen, E; Joensuu, E; Koli, K; Myllarniemi, M

Vartiainen, V (reprint author), Haartmaninkatu 3, Helsinki 00014, Finland.

INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2018; 544 (1): 121